_id
691843f13c536f8df2317723
Ticker
XFOR
Name
X4 Pharmaceuticals Inc
Exchange
NASDAQ
Address
61 North Beacon Street, Boston, MA, United States, 02134
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.x4pharma.com
Description
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally bioavailable selective antagonist of chemokine receptor C-X-C chemokine receptor type 4 (CXCR4) for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. The company also develops mavorixafor that is in Phase 3 4WARD clinical trial to evaluate the efficacy, safety, and tolerability of oral, once-daily mavorixafor with or without stable doses of G-CSF in people with congenital, acquired primary autoimmune, or idiopathic CN who are experiencing recurrent and/or serious infections. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications; and with Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand. The company is headquartered in Boston, Massachusetts.
Last Close
3.99
Volume
422015
Current Price
4
Change
0.04
Last Updated
2026-01-08T13:05:03.297Z
Image
https://logo.clearbit.com/www.x4pharma.com
Ipo Date
2017-11-16T00:00:00.000Z
Market Cap
349746752
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.6
Target Price
8
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1765000
Cost Of Revenue
351000
Gross Profit
1414000
Operating Expenses
28923000
Operating Income
-27509000
Interest Expense
2257000
Pretax Income
-29845000
Net Income
-29815000
Eps
-4.021993824354276
Dividends Per Share
-
Shares Outstanding
87436688
Income Tax Expense
-30000
EBITDA
-27365000
Operating Margin
-1558.5835694050993
Total Other Income Expense Net
-2336000
Cash
69856000
Short Term Investments
52562000
Receivables
1606000
Inventories
4080000
Total Current Assets
132805000
Property Plant Equipment
1993000
Total Assets
163555000
Payables
5053000
Short Term Debt
1200000
Long Term Debt
76062000
Total Liabilities
101936000
Equity
61619000
Bs_currency_symbol
USD
Depreciation
223000
Change In Working Capital
-606000
Cash From Operations
-27822000
Capital Expenditures
3000000
Cash From Investing
-28669000
Cash From Financing
86905000
Net Change In Cash
30413000
Cf_currency_symbol
USD
PE
-
PB
0.48121456044401895
ROE
-48.38604975738003
ROA
-18.229341811623
FCF
-30822000
Fcf Percent
-17.462889518413597
Piotroski FScore
1
Health Score
24
Deep Value Investing Score
4
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1765000
Quarters > 0 > income Statement > cost Of Revenue
351000
Quarters > 0 > income Statement > gross Profit
1414000
Quarters > 0 > income Statement > operating Expenses
28923000
Quarters > 0 > income Statement > operating Income
-27509000
Quarters > 0 > income Statement > interest Expense
2257000
Quarters > 0 > income Statement > pretax Income
-29845000
Quarters > 0 > income Statement > net Income
-29815000
Quarters > 0 > income Statement > eps
-4.021993824354276
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7412990
Quarters > 0 > income Statement > income Tax Expense
-30000
Quarters > 0 > income Statement > EBITDA
-27365000
Quarters > 0 > income Statement > operating Margin
-1558.5835694050993
Quarters > 0 > income Statement > total Other Income Expense Net
-2336000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
69856000
Quarters > 0 > balance Sheet > short Term Investments
52562000
Quarters > 0 > balance Sheet > receivables
1606000
Quarters > 0 > balance Sheet > inventories
4080000
Quarters > 0 > balance Sheet > total Current Assets
132805000
Quarters > 0 > balance Sheet > property Plant Equipment
1993000
Quarters > 0 > balance Sheet > total Assets
163555000
Quarters > 0 > balance Sheet > payables
5053000
Quarters > 0 > balance Sheet > short Term Debt
1200000
Quarters > 0 > balance Sheet > long Term Debt
76062000
Quarters > 0 > balance Sheet > total Liabilities
101936000
Quarters > 0 > balance Sheet > equity
61619000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-29815000
Quarters > 0 > cash Flow > depreciation
223000
Quarters > 0 > cash Flow > change In Working Capital
-606000
Quarters > 0 > cash Flow > cash From Operations
-27822000
Quarters > 0 > cash Flow > capital Expenditures
3000000
Quarters > 0 > cash Flow > cash From Investing
-28669000
Quarters > 0 > cash Flow > cash From Financing
86905000
Quarters > 0 > cash Flow > net Change In Cash
30413000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-4.021993824354276
Quarters > 0 > ratios > PB
0.48121456044401895
Quarters > 0 > ratios > ROE
-48.38604975738003
Quarters > 0 > ratios > ROA
-18.229341811623
Quarters > 0 > ratios > FCF
-30822000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-17.462889518413597
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1973000
Quarters > 1 > income Statement > cost Of Revenue
326000
Quarters > 1 > income Statement > gross Profit
1647000
Quarters > 1 > income Statement > operating Expenses
27879000
Quarters > 1 > income Statement > operating Income
-26232000
Quarters > 1 > income Statement > interest Expense
2232000
Quarters > 1 > income Statement > pretax Income
-25704000
Quarters > 1 > income Statement > net Income
-25741000
Quarters > 1 > income Statement > eps
-3.472418012165132
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
7412990
Quarters > 1 > income Statement > income Tax Expense
37000
Quarters > 1 > income Statement > EBITDA
-23117000
Quarters > 1 > income Statement > operating Margin
-1329.5489102889003
Quarters > 1 > income Statement > total Other Income Expense Net
528000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
39220000
Quarters > 1 > balance Sheet > short Term Investments
23731000
Quarters > 1 > balance Sheet > receivables
1865000
Quarters > 1 > balance Sheet > inventories
3170000
Quarters > 1 > balance Sheet > total Current Assets
72942000
Quarters > 1 > balance Sheet > property Plant Equipment
2900000
Quarters > 1 > balance Sheet > total Assets
105168000
Quarters > 1 > balance Sheet > payables
7709000
Quarters > 1 > balance Sheet > short Term Debt
1368000
Quarters > 1 > balance Sheet > long Term Debt
75841000
Quarters > 1 > balance Sheet > total Liabilities
101197000
Quarters > 1 > balance Sheet > equity
3971000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-25741000
Quarters > 1 > cash Flow > depreciation
355000
Quarters > 1 > cash Flow > change In Working Capital
-4208000
Quarters > 1 > cash Flow > cash From Operations
-29901000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
23112000
Quarters > 1 > cash Flow > cash From Financing
5631000
Quarters > 1 > cash Flow > net Change In Cash
-1019000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-3.472418012165132
Quarters > 1 > ratios > PB
7.4671266683455055
Quarters > 1 > ratios > ROE
-648.2246285570385
Quarters > 1 > ratios > ROA
-24.47607637304123
Quarters > 1 > ratios > FCF
-29901000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-15.155093765838824
Quarters > 1 > health Score
8
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
28807000
Quarters > 2 > income Statement > cost Of Revenue
4716000
Quarters > 2 > income Statement > gross Profit
24091000
Quarters > 2 > income Statement > operating Expenses
33534000
Quarters > 2 > income Statement > operating Income
-9443000
Quarters > 2 > income Statement > interest Expense
2201000
Quarters > 2 > income Statement > pretax Income
316000
Quarters > 2 > income Statement > net Income
282000
Quarters > 2 > income Statement > eps
0.0410535497946869
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
6869077.13
Quarters > 2 > income Statement > income Tax Expense
34000
Quarters > 2 > income Statement > EBITDA
2993000
Quarters > 2 > income Statement > operating Margin
-32.78022702815288
Quarters > 2 > income Statement > total Other Income Expense Net
9759000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
40257000
Quarters > 2 > balance Sheet > short Term Investments
46694000
Quarters > 2 > balance Sheet > receivables
1174000
Quarters > 2 > balance Sheet > inventories
3089000
Quarters > 2 > balance Sheet > total Current Assets
95697000
Quarters > 2 > balance Sheet > property Plant Equipment
4139000
Quarters > 2 > balance Sheet > total Assets
130013000
Quarters > 2 > balance Sheet > payables
11115000
Quarters > 2 > balance Sheet > short Term Debt
1303000
Quarters > 2 > balance Sheet > long Term Debt
75629000
Quarters > 2 > balance Sheet > total Liabilities
107069000
Quarters > 2 > balance Sheet > equity
22944000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
282000
Quarters > 2 > cash Flow > depreciation
476000
Quarters > 2 > cash Flow > change In Working Capital
-3280000
Quarters > 2 > cash Flow > cash From Operations
-12368000
Quarters > 2 > cash Flow > capital Expenditures
3000000
Quarters > 2 > cash Flow > cash From Investing
-3138000
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-15434000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.0410535497946869
Quarters > 2 > ratios > PB
1.1975378539051604
Quarters > 2 > ratios > ROE
1.2290794979079498
Quarters > 2 > ratios > ROA
0.21690138678439846
Quarters > 2 > ratios > FCF
-15368000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.5334814454820009
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1434000
Quarters > 3 > income Statement > cost Of Revenue
302000
Quarters > 3 > income Statement > gross Profit
1132000
Quarters > 3 > income Statement > operating Expenses
36847000
Quarters > 3 > income Statement > operating Income
-35715000
Quarters > 3 > income Statement > interest Expense
2304000
Quarters > 3 > income Statement > pretax Income
-39563000
Quarters > 3 > income Statement > net Income
-39821000
Quarters > 3 > income Statement > eps
-5.941659241669109
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
6701999.96
Quarters > 3 > income Statement > income Tax Expense
258000
Quarters > 3 > income Statement > EBITDA
-36986000
Quarters > 3 > income Statement > operating Margin
-2490.5857740585775
Quarters > 3 > income Statement > total Other Income Expense Net
-3848000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
55699000
Quarters > 3 > balance Sheet > short Term Investments
46361000
Quarters > 3 > balance Sheet > receivables
1710000
Quarters > 3 > balance Sheet > inventories
2817000
Quarters > 3 > balance Sheet > total Current Assets
112175000
Quarters > 3 > balance Sheet > property Plant Equipment
4841000
Quarters > 3 > balance Sheet > total Assets
146447000
Quarters > 3 > balance Sheet > payables
8621000
Quarters > 3 > balance Sheet > short Term Debt
1251000
Quarters > 3 > balance Sheet > long Term Debt
75425000
Quarters > 3 > balance Sheet > total Liabilities
124298000
Quarters > 3 > balance Sheet > equity
22149000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-39821000
Quarters > 3 > cash Flow > depreciation
273000
Quarters > 3 > cash Flow > change In Working Capital
1196000
Quarters > 3 > cash Flow > cash From Operations
-32995000
Quarters > 3 > cash Flow > capital Expenditures
41000
Quarters > 3 > cash Flow > cash From Investing
-8621000
Quarters > 3 > cash Flow > cash From Financing
135000
Quarters > 3 > cash Flow > net Change In Cash
-41725000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-5.941659241669109
Quarters > 3 > ratios > PB
1.210348089755745
Quarters > 3 > ratios > ROE
-179.7868978283444
Quarters > 3 > ratios > ROA
-27.191407130224587
Quarters > 3 > ratios > FCF
-33036000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-23.03765690376569
Quarters > 3 > health Score
17
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2557000
Annuals > 0 > income Statement > cost Of Revenue
797000
Annuals > 0 > income Statement > gross Profit
1760000
Annuals > 0 > income Statement > operating Expenses
38161000
Annuals > 0 > income Statement > operating Income
-36401000
Annuals > 0 > income Statement > interest Expense
8768000
Annuals > 0 > income Statement > pretax Income
-37140000
Annuals > 0 > income Statement > net Income
-37450000
Annuals > 0 > income Statement > eps
-5.587885047431371
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
6701999
Annuals > 0 > income Statement > income Tax Expense
310000
Annuals > 0 > income Statement > EBITDA
-27576000
Annuals > 0 > income Statement > operating Margin
-1423.5823230348064
Annuals > 0 > income Statement > total Other Income Expense Net
-739000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
55699000
Annuals > 0 > balance Sheet > short Term Investments
46361000
Annuals > 0 > balance Sheet > receivables
1710000
Annuals > 0 > balance Sheet > inventories
2817000
Annuals > 0 > balance Sheet > total Current Assets
112175000
Annuals > 0 > balance Sheet > property Plant Equipment
4841000
Annuals > 0 > balance Sheet > total Assets
146447000
Annuals > 0 > balance Sheet > payables
8621000
Annuals > 0 > balance Sheet > short Term Debt
1251000
Annuals > 0 > balance Sheet > long Term Debt
75425000
Annuals > 0 > balance Sheet > total Liabilities
124298000
Annuals > 0 > balance Sheet > equity
22149000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-37450000
Annuals > 0 > cash Flow > depreciation
796000
Annuals > 0 > cash Flow > change In Working Capital
2675000
Annuals > 0 > cash Flow > cash From Operations
-130901000
Annuals > 0 > cash Flow > capital Expenditures
326000
Annuals > 0 > cash Flow > cash From Investing
66990000
Annuals > 0 > cash Flow > cash From Financing
20294000
Annuals > 0 > cash Flow > net Change In Cash
-43773000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-5.587885047431371
Annuals > 0 > ratios > PB
1.2103479163844868
Annuals > 0 > ratios > ROE
-169.08212560386474
Annuals > 0 > ratios > ROA
-25.572391377085225
Annuals > 0 > ratios > FCF
-131227000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-51.320688306609306
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1996000
Annuals > 1 > income Statement > gross Profit
-1996000
Annuals > 1 > income Statement > operating Expenses
107522000
Annuals > 1 > income Statement > operating Income
-107522000
Annuals > 1 > income Statement > interest Expense
5777000
Annuals > 1 > income Statement > pretax Income
-101089000
Annuals > 1 > income Statement > net Income
-101167000
Annuals > 1 > income Statement > eps
-17.06861652680407
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5927076.74
Annuals > 1 > income Statement > income Tax Expense
78000
Annuals > 1 > income Statement > EBITDA
-94893000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
6433000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
99216000
Annuals > 1 > balance Sheet > short Term Investments
15000000
Annuals > 1 > balance Sheet > receivables
562000
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
122076000
Annuals > 1 > balance Sheet > property Plant Equipment
6395000
Annuals > 1 > balance Sheet > total Assets
147258000
Annuals > 1 > balance Sheet > payables
8947000
Annuals > 1 > balance Sheet > short Term Debt
1099000
Annuals > 1 > balance Sheet > long Term Debt
54570000
Annuals > 1 > balance Sheet > total Liabilities
96159000
Annuals > 1 > balance Sheet > equity
51099000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-101167000
Annuals > 1 > cash Flow > depreciation
419000
Annuals > 1 > cash Flow > change In Working Capital
344000
Annuals > 1 > cash Flow > cash From Operations
-96512000
Annuals > 1 > cash Flow > capital Expenditures
60000
Annuals > 1 > cash Flow > cash From Investing
-14883000
Annuals > 1 > cash Flow > cash From Financing
88516000
Annuals > 1 > cash Flow > net Change In Cash
-22780000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-17.06861652680407
Annuals > 1 > ratios > PB
0.46396811992406894
Annuals > 1 > ratios > ROE
-197.98234799115443
Annuals > 1 > ratios > ROA
-68.70051202651129
Annuals > 1 > ratios > FCF
-96572000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1994000
Annuals > 2 > income Statement > gross Profit
-1994000
Annuals > 2 > income Statement > operating Expenses
87569000
Annuals > 2 > income Statement > operating Income
-87569000
Annuals > 2 > income Statement > interest Expense
3993000
Annuals > 2 > income Statement > pretax Income
-93839000
Annuals > 2 > income Statement > net Income
-93867000
Annuals > 2 > income Statement > eps
-44.32861640592332
Annuals > 2 > income Statement > dividends Per Share
12
Annuals > 2 > income Statement > shares Outstanding
2117526.05
Annuals > 2 > income Statement > income Tax Expense
28000
Annuals > 2 > income Statement > EBITDA
-89333000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-6270000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
121718000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
1152000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
128677000
Annuals > 2 > balance Sheet > property Plant Equipment
8333000
Annuals > 2 > balance Sheet > total Assets
155586000
Annuals > 2 > balance Sheet > payables
7777000
Annuals > 2 > balance Sheet > short Term Debt
2513000
Annuals > 2 > balance Sheet > long Term Debt
32304000
Annuals > 2 > balance Sheet > total Liabilities
81535000
Annuals > 2 > balance Sheet > equity
74051000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-93867000
Annuals > 2 > cash Flow > depreciation
513000
Annuals > 2 > cash Flow > change In Working Capital
5736000
Annuals > 2 > cash Flow > cash From Operations
-77102000
Annuals > 2 > cash Flow > capital Expenditures
103000
Annuals > 2 > cash Flow > cash From Investing
-103000
Annuals > 2 > cash Flow > cash From Financing
117230000
Annuals > 2 > cash Flow > net Change In Cash
39920000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-44.32861640592332
Annuals > 2 > ratios > PB
0.1143820367044334
Annuals > 2 > ratios > ROE
-126.75993571997677
Annuals > 2 > ratios > ROA
-60.33126373838263
Annuals > 2 > ratios > FCF
-77205000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1892000
Annuals > 3 > income Statement > gross Profit
-1892000
Annuals > 3 > income Statement > operating Expenses
85107000
Annuals > 3 > income Statement > operating Income
-85107000
Annuals > 3 > income Statement > interest Expense
3642000
Annuals > 3 > income Statement > pretax Income
-88679000
Annuals > 3 > income Statement > net Income
-88696000
Annuals > 3 > income Statement > eps
-103.34007625699765
Annuals > 3 > income Statement > dividends Per Share
13943000
Annuals > 3 > income Statement > shares Outstanding
858292.38
Annuals > 3 > income Statement > income Tax Expense
17000
Annuals > 3 > income Statement > EBITDA
-84538000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-3572000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
81787000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
747000
Annuals > 3 > balance Sheet > inventories
-747000
Annuals > 3 > balance Sheet > total Current Assets
87878000
Annuals > 3 > balance Sheet > property Plant Equipment
10224000
Annuals > 3 > balance Sheet > total Assets
117176000
Annuals > 3 > balance Sheet > payables
4283000
Annuals > 3 > balance Sheet > short Term Debt
1870000
Annuals > 3 > balance Sheet > long Term Debt
33139000
Annuals > 3 > balance Sheet > total Liabilities
52764000
Annuals > 3 > balance Sheet > equity
64412000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-88696000
Annuals > 3 > cash Flow > depreciation
499000
Annuals > 3 > cash Flow > change In Working Capital
-1498000
Annuals > 3 > cash Flow > cash From Operations
-70905000
Annuals > 3 > cash Flow > capital Expenditures
615000
Annuals > 3 > cash Flow > cash From Investing
-615000
Annuals > 3 > cash Flow > cash From Financing
74245000
Annuals > 3 > cash Flow > net Change In Cash
2406000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-103.34007625699765
Annuals > 3 > ratios > PB
0.05330015400856983
Annuals > 3 > ratios > ROE
-137.70104949388312
Annuals > 3 > ratios > ROA
-75.69468150474499
Annuals > 3 > ratios > FCF
-71520000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-4.021993824354276
Valuation > metrics > PB
0.48121456044401895
Valuation > final Score
70
Valuation > verdict
51.9% Undervalued
Profitability > metrics > ROE
-48.38604975738003
Profitability > metrics > ROA
-22.450208952976165
Profitability > metrics > Net Margin
-16.892351274787536
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.654294941495318
Risk > metrics > Interest Coverage
-12.188303057155515
Risk > final Score
-19
Risk > verdict
High
Liquidity > metrics > Current Ratio
21.2386054693747
Liquidity > metrics > Quick Ratio
20.58611866304174
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
100
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
5
Prev Profitabilities > 2
0
Prev Risks > 0
-41
Prev Risks > 1
-11
Prev Risks > 2
-56
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:50:36.312Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.69
Earnings History > 0 > eps Estimate
-0.125
Earnings History > 0 > eps Difference
-0.565
Earnings History > 0 > surprise Percent
-452
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-08
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-3.47
Earnings History > 1 > eps Estimate
-0.0883
Earnings History > 1 > eps Difference
-3.3817
Earnings History > 1 > surprise Percent
-3829.7848
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.04
Earnings History > 2 > eps Estimate
-3.75
Earnings History > 2 > eps Difference
3.79
Earnings History > 2 > surprise Percent
101.0667
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-19
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2
Earnings History > 3 > eps Estimate
-0.1575
Earnings History > 3 > eps Difference
-0.0425
Earnings History > 3 > surprise Percent
-26.9841
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.18
Earnings History > 4 > eps Estimate
-0.17
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-5.8824
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.07
Earnings History > 5 > eps Estimate
0.01
Earnings History > 5 > eps Difference
-0.08
Earnings History > 5 > surprise Percent
-800
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.26
Earnings History > 6 > eps Estimate
-0.16
Earnings History > 6 > eps Difference
-0.1
Earnings History > 6 > surprise Percent
-62.5
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-21
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1
Earnings History > 7 > eps Estimate
-0.15
Earnings History > 7 > eps Difference
0.05
Earnings History > 7 > surprise Percent
33.3333
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.01
Earnings History > 8 > eps Estimate
-0.15
Earnings History > 8 > eps Difference
0.14
Earnings History > 8 > surprise Percent
93.3333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.33
Earnings History > 9 > eps Estimate
-0.16
Earnings History > 9 > eps Difference
-0.17
Earnings History > 9 > surprise Percent
-106.25
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.16
Earnings History > 10 > eps Estimate
-0.22
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
27.2727
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-21
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.29
Earnings History > 11 > eps Estimate
-0.24
Earnings History > 11 > eps Difference
-0.05
Earnings History > 11 > surprise Percent
-20.8333
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.26
Earnings History > 12 > eps Estimate
-0.3
Earnings History > 12 > eps Difference
0.04
Earnings History > 12 > surprise Percent
13.3333
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.6
Earnings History > 13 > eps Estimate
-0.64
Earnings History > 13 > eps Difference
0.04
Earnings History > 13 > surprise Percent
6.25
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.72
Earnings History > 14 > eps Estimate
-0.61
Earnings History > 14 > eps Difference
-0.11
Earnings History > 14 > surprise Percent
-18.0328
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-17
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.9
Earnings History > 15 > eps Estimate
-0.68
Earnings History > 15 > eps Difference
-0.22
Earnings History > 15 > surprise Percent
-32.3529
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.76
Earnings History > 16 > eps Estimate
-0.72
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-5.5556
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-03
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.74
Earnings History > 17 > eps Estimate
-0.74
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.3
Earnings History > 18 > eps Estimate
-0.86
Earnings History > 18 > eps Difference
-0.44
Earnings History > 18 > surprise Percent
-51.1628
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-04
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.91
Earnings History > 19 > eps Estimate
-0.9
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-1.1111
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.74
Earnings History > 20 > eps Estimate
-0.76
Earnings History > 20 > eps Difference
0.02
Earnings History > 20 > surprise Percent
2.6316
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-07-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.76
Earnings History > 21 > eps Estimate
-0.72
Earnings History > 21 > eps Difference
-0.04
Earnings History > 21 > surprise Percent
-5.5556
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.56
Earnings History > 22 > eps Estimate
-0.8
Earnings History > 22 > eps Difference
0.24
Earnings History > 22 > surprise Percent
30
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.66
Earnings History > 23 > eps Estimate
-0.83
Earnings History > 23 > eps Difference
0.17
Earnings History > 23 > surprise Percent
20.4819
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-07
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.94
Earnings History > 24 > eps Estimate
-1.07
Earnings History > 24 > eps Difference
0.13
Earnings History > 24 > surprise Percent
12.1495
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-07
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.02
Earnings History > 25 > eps Estimate
-0.96
Earnings History > 25 > eps Difference
-0.06
Earnings History > 25 > surprise Percent
-6.25
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-15
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-6.67
Earnings History > 26 > eps Estimate
-6.67
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
0
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-11
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-3.92
Earnings History > 27 > eps Estimate
-4.44
Earnings History > 27 > eps Difference
0.52
Earnings History > 27 > surprise Percent
11.7117
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-09
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
BeforeMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-4.56
Earnings History > 28 > eps Estimate
-3.88
Earnings History > 28 > eps Difference
-0.68
Earnings History > 28 > surprise Percent
-17.5258
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-13
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
BeforeMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-5.1
Earnings History > 29 > eps Estimate
-4.9
Earnings History > 29 > eps Difference
-0.2
Earnings History > 29 > surprise Percent
-4.0816
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-10
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
BeforeMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-4.44
Earnings History > 30 > eps Estimate
-6.24
Earnings History > 30 > eps Difference
1.8
Earnings History > 30 > surprise Percent
28.8462
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-09
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
BeforeMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-10.08
Earnings History > 31 > eps Estimate
-17.8
Earnings History > 31 > eps Difference
7.72
Earnings History > 31 > surprise Percent
43.3708
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-17
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
AfterMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-24.36
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-09-20
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.53
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.53
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-04
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.5
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.5
Earnings History > 34 > surprise Percent
-
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally bioavailable selective antagonist of chemokine receptor C-X-C chemokine receptor type 4 (CXCR4) for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. The company also develops mavorixafor that is in Phase 3 4WARD clinical trial to evaluate the efficacy, safety, and tolerability of oral, once-daily mavorixafor with or without stable doses of G-CSF in people with congenital, acquired primary autoimmune, or idiopathic CN who are experiencing recurrent and/or serious infections. It has a license agreement with Abbisko Therapeutics Co Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications; and with Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand. The company is headquartered in Boston, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWhat hedge funds are buying XFOR - Stock Surge & Fast Entry Momentum Trade Alerts bollywoodhelpline.com
Read more →Sentiment Review: Whats the beta of XFOR stock - Market Activity Report & AI Enhanced Trade Execution Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$8
Analyst Picks
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 10.61% of the total shares of X4 Pharmaceuticals Inc
1.
Bain Capital Life Sciences Investors, LLC(2.5117%)
since
2025/06/30
2.
Kingdon Capital Management LLC(1.0394%)
since
2025/06/30
3.
Vanguard Group Inc(1.033%)
since
2025/06/30
4.
BlackRock Inc(0.7984%)
since
2025/06/30
5.
Vanguard Total Stock Mkt Idx Inv(0.6936%)
since
2025/07/31
6.
GSA Capital Partners LLP(0.5912%)
since
2025/06/30
7.
UBS Group AG(0.4898%)
since
2025/06/30
8.
Jane Street Group LLC(0.4336%)
since
2025/06/30
9.
Bank of America Corp(0.3578%)
since
2025/06/30
10.
UBS O'Connor LLC(0.3564%)
since
2025/06/30
11.
Millennium Management LLC(0.3477%)
since
2025/06/30
12.
Pale Fire Capital SE(0.2675%)
since
2025/06/30
13.
Geode Capital Management, LLC(0.2189%)
since
2025/06/30
14.
Vanguard Institutional Extnd Mkt Idx Tr(0.1975%)
since
2025/07/31
15.
Squarepoint Ops LLC(0.1736%)
since
2025/06/30
16.
Susquehanna International Group, LLP(0.1551%)
since
2025/06/30
17.
AQR Capital Management LLC(0.1175%)
since
2025/06/30
18.
Fidelity Extended Market Index(0.1082%)
since
2025/07/31
19.
Point72 Asset Management, L.P.(0.0965%)
since
2025/06/30
20.
Goldman Sachs Group Inc(0.084%)
since
2025/06/30
21.
AQR Small Cap Multi-Style I(0.0832%)
since
2025/06/30
22.
Renaissance Technologies Corp(0.0774%)
since
2025/06/30
23.
State Street Corp(0.0692%)
since
2025/06/30
24.
Extended Equity Market Fund K(0.0494%)
since
2025/06/30
25.
Fidelity Total Market Index(0.0352%)
since
2025/07/31
26.
Fidelity Series Total Market Index(0.0297%)
since
2025/07/31
27.
Rhumbline Advisers(0.028%)
since
2025/03/31
28.
Spartan Extended Market Index Pool F(0.0216%)
since
2025/07/31
29.
Northern Trust Extended Eq Market Idx(0.0214%)
since
2025/06/30
30.
NT Ext Equity Mkt Idx Fd - L(0.0214%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - NL(0.0176%)
since
2025/06/30
32.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0168%)
since
2024/12/31
33.
Fidelity Nasdaq Composite Index(0.014%)
since
2025/07/31
34.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0136%)
since
2025/06/30
35.
Spartan Total Market Index Pool G(0.0134%)
since
2025/07/31
36.
Vifag 2002 SICAV(0.0111%)
since
2025/07/31
37.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0051%)
since
2024/12/31
38.
SSgA Russell Small Cap Completeness Idx(0.0035%)
since
2025/03/31
39.
SSgA Russell 2000 Growth Index Strategy(0.0025%)
since
2025/03/31
40.
SSgA U.S. Total Market Index Strategy(0.0021%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.69
EPS Estimate
-0.125
EPS Difference
-0.565
Surprise Percent
-452%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.